| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |